Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

GeoVax Labs (GOVX) Share-based Compensation (2016 - 2025)

GeoVax Labs (GOVX) has disclosed Share-based Compensation for 16 consecutive years, with $277546.0 as the latest value for Q3 2025.

  • On a quarterly basis, Share-based Compensation rose 113.62% to $277546.0 in Q3 2025 year-over-year; TTM through Sep 2025 was $1.0 million, a 54.03% increase, with the full-year FY2024 number at $528644.0, down 50.82% from a year prior.
  • Share-based Compensation was $277546.0 for Q3 2025 at GeoVax Labs, down from $292740.0 in the prior quarter.
  • In the past five years, Share-based Compensation ranged from a high of $297947.0 in Q3 2023 to a low of $46272.0 in Q3 2021.
  • A 5-year average of $198807.2 and a median of $222872.0 in 2022 define the central range for Share-based Compensation.
  • Peak YoY movement for Share-based Compensation: soared 1179.83% in 2021, then plummeted 62.29% in 2024.
  • GeoVax Labs' Share-based Compensation stood at $46272.0 in 2021, then soared by 442.83% to $251179.0 in 2022, then rose by 4.09% to $261458.0 in 2023, then tumbled by 46.7% to $139345.0 in 2024, then skyrocketed by 99.18% to $277546.0 in 2025.
  • Per Business Quant, the three most recent readings for GOVX's Share-based Compensation are $277546.0 (Q3 2025), $292740.0 (Q2 2025), and $292744.0 (Q1 2025).